The biopark

Genopole® is France’s leading biotech- and biotherapy-dedicated science and business park.

A pioneering, sector-leading location.

  • 21 academic research laboratories, including the CEA Genomics Institute (which houses the French national sequencing and genotyping facilities).
  • 73 biotech companies
  • 18 shared-access technology platforms and technical facilities
  • 91,929 m2 of real estate
  • 2,107 staff on the biopark

Dynamism, synergy and innovation

The Evry-Corbeil Genopole®’s success is largely based on what is a rare feature in France: public- and private-sector research units, university teaching and hi-tech life science businesses at a single location.

Genopole®’s strategic mission is to transform scientific progress into innovative treatments for human healthcare.

While remaining faithful to its founding objective, Genopole® has shaped its own identity and is now France’s benchmark biopark.

Genopole®’s activities

Genopole® unites the skills, resources and funding needed to achieve its objectives: funding research, promoting therapeutic innovation and transferring technology to industry. At the time of its launch in 1998, Genopole® had a (...)

[+] More

The Genopole® team

Genopole® is organized into several departments - General Management, Finance & Administration, Research and Teaching, Enterprise, Infrastructure & Technical Facilities, International, Marketing & Public Relations - and has (...)

[+] More